November 4, 2021
CDC recommends Pfizer/BioNTech pediatric COVID-19 vaccine
Editor's Note
The Centers for Disease Control and Prevention (CDC), on November 2, recommended broad use of the Pfizer/BioNTech COVID-19 vaccine for children ages 5 to 11.
Distribution of the vaccine to clinics, children’s hospitals, and pediatricians’ offices across the country have started, with plans to scale up to full capacity starting the week of November 8.
Free Daily News
- OR traffic, workflow disruptions drive infection risk
- Proactive strategies help healthcare supply chains withstand tariff pressures
- Study: EEG-guided anesthesia halves anesthetic use, accelerates recovery in pediatric surgery
- Study: Longer shifts, understaffing increase nurse sickness absence
- Power loss risks prompt FDA Class 1 recall designation for heart pump accessories
- Therapy dogs ease nurse burnout, boost morale
- Personalized perioperative pain management reduces opioid use
- Study: Colibactin-producing gut bacteria fuel colorectal cancer surge
- Augmented reality gains FDA nod, 10k-case milestone in orthopedics, strides in outpatient surgery
- Smart patient selection anchors DISC’s high-acuity spine ASC model
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement